loading
Schlusskurs vom Vortag:
$3.47
Offen:
$3.65
24-Stunden-Volumen:
24,898
Relative Volume:
0.08
Marktkapitalisierung:
$13.39M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.60M
KGV:
-4.0562
EPS:
-0.89
Netto-Cashflow:
$-23.48M
1W Leistung:
-9.98%
1M Leistung:
-1.63%
6M Leistung:
-76.17%
1J Leistung:
-91.25%
1-Tages-Spanne:
Value
$3.48
$3.69
1-Wochen-Bereich:
Value
$3.44
$4.36
52-Wochen-Spanne:
Value
$3.09
$45.45

Briacell Therapeutics Corp Stock (BCTX) Company Profile

Name
Firmenname
Briacell Therapeutics Corp
Name
Telefon
(604) 921-1810
Name
Adresse
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Name
Mitarbeiter
12
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-28
Name
Neueste SEC-Einreichungen
Name
BCTX's Discussions on Twitter

Vergleichen Sie BCTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
BCTX
Briacell Therapeutics Corp
3.61 13.39M 0 -16.60M -23.48M -0.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-02-14 Eingeleitet H.C. Wainwright Buy

Briacell Therapeutics Corp Aktie (BCTX) Neueste Nachrichten

pulisher
02:09 AM

BriaCell Therapeutics (NASDAQ:BCTX) Trading 4% Higher – Time to Buy? - Defense World

02:09 AM
pulisher
Mar 31, 2025

(BCT) Technical Patterns and Signals (BCT:CA) - news.stocktradersdaily.com

Mar 31, 2025
pulisher
Mar 28, 2025

BriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT) - The Globe and Mail

Mar 28, 2025
pulisher
Mar 27, 2025

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

BriaCell to Showcase Cancer Immunotherapy Advances at AACR 2025 - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

New Clinical Data: BriaCell's Registration Trial Results for Advanced Breast Cancer Treatment - Stock Titan

Mar 26, 2025
pulisher
Mar 26, 2025

Where Will Rigetti Computing Stock Be in 1 Year? - The Globe and Mail

Mar 26, 2025
pulisher
Mar 26, 2025

Dan Ives Is Pounding the Table on Microsoft Stock. Should You Buy the Dip? - The Globe and Mail

Mar 26, 2025
pulisher
Mar 25, 2025

Quantum Gamble? Is IonQ's Stock an Opportunity or a Mirage? - The Globe and Mail

Mar 25, 2025
pulisher
Mar 24, 2025

(BCT) Stock Evaluation Report (BCT:CA) - Stock Traders Daily

Mar 24, 2025
pulisher
Mar 22, 2025

(BCT) Market Dynamics and Trading Signals (BCT:CA) - news.stocktradersdaily.com

Mar 22, 2025
pulisher
Mar 20, 2025

What To Expect From Carnival’s (CCL) Q1 Earnings - The Globe and Mail

Mar 20, 2025
pulisher
Mar 20, 2025

BriaCell’s Phase 3 Breast Cancer Trial Proceeds After Safety Review By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Stocks In Play: BriaCell Therapeutics Corp By Baystreet.ca - Investing.com Canada

Mar 20, 2025
pulisher
Mar 20, 2025

(BCT) Technical Analysis and Trading Signals (BCT:CA) - Stock Traders Daily

Mar 20, 2025
pulisher
Mar 20, 2025

BriaCell Therapeutics Corp - Baystreet.ca

Mar 20, 2025
pulisher
Mar 20, 2025

Stocks in play: BriaCell Therapeutics Corp - The Globe and Mail

Mar 20, 2025
pulisher
Mar 20, 2025

BriaCell Therapeutics Says Data Safety Monitoring Board Recommends Continuation of Phase 3 Trial in Metastatic Breast Cancer - MarketScreener

Mar 20, 2025
pulisher
Mar 20, 2025

BriaCell’s Phase 3 Metastatic Breast Cancer Study Receives Positive DSMB Review - TipRanks

Mar 20, 2025
pulisher
Mar 20, 2025

BriaCell’s Phase 3 Breast Cancer Trial Proceeds After Safety Review - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Second Data Safety Monitoring Board Issues Positive - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Major Milestone: BriaCell's Breast Cancer Immunotherapy Passes Critical Safety Review in Phase 3 Trial - Stock Titan

Mar 20, 2025
pulisher
Mar 20, 2025

3 Reasons DRS is Risky and 1 Stock to Buy Instead - The Globe and Mail

Mar 20, 2025
pulisher
Mar 17, 2025

Briacell Therapeutics Corp reports results for the quarter ended January 31Earnings Summary - TradingView

Mar 17, 2025
pulisher
Mar 16, 2025

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Significant Growth in Short Interest - Defense World

Mar 16, 2025
pulisher
Mar 14, 2025

Briacell Therapeutics Corp expected to post a loss of $1.12 a shareEarnings Preview - TradingView

Mar 14, 2025
pulisher
Mar 13, 2025

3 Industrials Stocks Walking a Fine Line - The Globe and Mail

Mar 13, 2025
pulisher
Mar 13, 2025

BriaCell Therapeutics (OTCMKTS:BCTXF) Trading 0.3% Higher – Here’s Why - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

BriaCell Therapeutics Reports Continued Financial Challenges - TipRanks

Mar 13, 2025
pulisher
Mar 12, 2025

BriaCell subsidiary reports interim financial results By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

BriaCell Therapeutics Corp. SEC 10-Q Report - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

BriaCell subsidiary reports interim financial results - Investing.com India

Mar 12, 2025
pulisher
Mar 10, 2025

BriaCell Therapeutics (BCTX) Projected to Post Quarterly Earnings on Monday - Defense World

Mar 10, 2025
pulisher
Mar 03, 2025

BCTX stock touches 52-week low at $3.31 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 03, 2025

BCTX stock touches 52-week low at $3.31 amid sharp annual decline - Investing.com

Mar 03, 2025
pulisher
Mar 02, 2025

BriaCell Therapeutics Corp. (NASDAQ:BCTX) Sees Significant Increase in Short Interest - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

BriaCell Therapeutics (NASDAQ:BCTX) versus Actinium Pharmaceuticals (NYSE:ATNM) Critical Analysis - Defense World

Mar 01, 2025
pulisher
Feb 25, 2025

Dye & Durham Limited - Baystreet.ca

Feb 25, 2025
pulisher
Feb 22, 2025

(BCT) Equity Trading Insights (BCT:CA) - Stock Traders Daily

Feb 22, 2025
pulisher
Feb 20, 2025

(BCT) Market Performance Analysis (BCT:CA) - Stock Traders Daily

Feb 20, 2025
pulisher
Feb 18, 2025

BriaCell Therapeutics Corp (NASDAQ: BCTX) – An Analysis Is What You Need - Stocks Register

Feb 18, 2025
pulisher
Feb 18, 2025

(BCT) Investment Analysis (BCT:CA) - Stock Traders Daily

Feb 18, 2025
pulisher
Feb 15, 2025

(BCT) Trading Advice (BCT:CA) - Stock Traders Daily

Feb 15, 2025
pulisher
Feb 14, 2025

BriaCell Therapeutics: A Biotech Stock on the Brink of a Turnaround? - HPBL

Feb 14, 2025
pulisher
Feb 14, 2025

Biotechs on the Brink: 2 Stocks With Huge Potential - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

BriaCell regains Nasdaq compliance with bid price By Investing.com - Investing.com Australia

Feb 14, 2025
pulisher
Feb 13, 2025

BriaCell regains Nasdaq compliance with bid price - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Briacell Therapeutics CorpRegains Compliance With Nasdaq Minimum Bid Price Requirement - Marketscreener.com

Feb 13, 2025

Finanzdaten der Briacell Therapeutics Corp-Aktie (BCTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
Kapitalisierung:     |  Volumen (24h):